angiotensin ii has been researched along with Cardiometabolic Syndrome in 66 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 27 (40.91) | 29.6817 |
| 2010's | 37 (56.06) | 24.3611 |
| 2020's | 2 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Labandeira, CM; Labandeira-Garcia, JL; Lanciego, JL; Pedrosa, MA; Quijano, A; Rodriguez-Perez, AI; Sanchez-Andrade, M; Suarez-Quintanilla, JA; Valenzuela, R | 1 |
| Ferder, L; García Menéndez, S; Inserra, F; Manucha, W; Mazzei, L; Sanz, RL | 1 |
| Chen, JS; Chou, CL; Fang, TC; Lin, H | 1 |
| Ayme-Dietrich, E; Birling, MC; Bouabout, G; Champy, MF; Fertak, LE; Herault, Y; Jacob, H; Madeira, L; Monassier, L; Mudgett, J; Pavlovic, G; Petit-Demoulière, B; Sorg, T | 1 |
| Bach, D; Bode, D; Doerr, R; Guthof, T; Heinzel, FR; Hohendanner, F; Jeuthe, S; Pieske, BM; Primessnig, U; Reimers, S; Wakula, P; Zhang, K | 1 |
| Hayashi, M; Hirokawa, F; Jin, D; Masubuchi, S; Miyaoka, Y; Ozeki, M; Takai, S; Tashiro, K; Uchiyama, K | 1 |
| Huang, LT; Lin, IC; Lin, YJ; Sheen, JM; Tain, YL; Tiao, MM; Tsai, CC; Tsai, WL; Yu, HR | 1 |
| Ascaso, JF; Collado, A; Domingo, E; Escudero, P; Marques, P; Martinez-Hervás, S; Piqueras, L; Real, JT; Rius, C; Sanz, MJ | 1 |
| Kohan, DE; Ramkumar, N | 1 |
| Nistala, R; Whaley-Connell, A | 1 |
| Kataoka, K; Katayama, T; Kim-Mitsuyama, S; Koibuchi, N; Maeda, M; Matsui, K; Mingjie, M; Nakagawa, T; Ogawa, H; Sueta, D; Toyama, K; Uekawa, K; Waki, H; Yasuda, O | 1 |
| Carranza, A; Dominici, FP; Fernández, BE; Giani, JF; Höcht, C; Mayer, MA; Muñoz, MC; Puyó, AM; Taira, CA | 1 |
| Ding, QL; Guan, QH; Hu, DH; Yan, SM; Zhang, X; Zhang, YT; Zheng, HL | 1 |
| Abd El-Aziz, TA; Mohamed, RH; Rezk, NA | 1 |
| Carreón-Torres, E; Castrejón-Tellez, V; Del Valle-Mondragón, L; Díaz-Díaz, E; Guarner-Lans, V; Rubio-Ruíz, ME | 1 |
| Horita, S; Nakamura, M; Satoh, N; Seki, G; Shirai, A; Suzuki, M; Yamada, H; Yamazaki, O | 1 |
| Chandramouli, C; Fernando, HA; Kadir, KA; Lam, YL; Rosli, D; Sainsbury, A; Ton, SH; Yaw, HP; Yong, ST | 1 |
| Azhar, A; El-Bassossy, HM | 1 |
| Byrne, D; Martino, HS; Mertens-Talcott, SU; Noratto, G; Simbo, S | 1 |
| Kurabayashi, M; Nakamura, T; Okajima, F; Sato, K; Tomono, S; Uchiyama, T | 1 |
| Abraham, NG; Gotlinger, K; Jiang, H; Maher, E; O'Hanlon, K; Peterson, SJ; Shapiro, JI; Singh, SP; Sodhi, K; Vanella, L | 1 |
| Anagnostopoulou, A; Antunes, TT; Callera, GE; Dulak-Lis, MG; He, Y; Jaisser, F; Montezano, AC; Nguyen Dinh Cat, A; Sanchez, A; Touyz, RM; Tsiropoulou, S | 1 |
| Carreón-Torres, E; Del Valle-Mondragón, L; Díaz-Díaz, E; Guarner-Lans, V; Ibarra-Lara, L; Rubio-Ruiz, ME; Sánchez-Aguilar, M; Sánchez-Mendoza, A; Soria-Castro, E; Vázquez-Meza, H | 1 |
| Kagota, S; Kunitomo, M; Nakamura, K; Nejime, N; Shinozuka, K; Tada, Y | 1 |
| Brillante, DG; Brillante, RE; Howes, LG; O'Sullivan, AJ | 1 |
| Day, RO; Graham, GG; Indraratna, PL; Williams, KM | 1 |
| Avery, MA; Carvalho, PB; Chittiboyina, AG; Karamyan, VT; Kurtz, TW; Mizuno, CS; Patny, A; Pershadsingh, HA; Shah, FH; Speth, RC | 1 |
| Rizvi, AA | 1 |
| Bilan, VP; Jackson, EK; Tofovic, DS | 1 |
| Fukushima, K; Kagota, S; Kunitomo, M; Mori, H; Nakamura, K; Nejime, N; Shinozuka, K; Sugimura, K; Tada, Y; Umetani, K | 1 |
| Jin, D; Miyazaki, M; Takai, S | 1 |
| Medvedev, IN; Simonenko, VB; Tolmachev, VV | 1 |
| Derosa, G; Fogari, R; Lazzari, P; Maffioli, P; Mugellini, A; Zoppi, A | 1 |
| Araki, H; Araki, S; Chin-Kanasaki, M; Deji, N; Haneda, M; Isshiki, K; Kashiwagi, A; Koya, D; Kume, S; Maegawa, H; Nishiyama, A; Tanaka, Y; Uzu, T | 1 |
| Dong, X; Liu, D; Sun, J; Xiao, X; Zhang, F; Zhang, X | 1 |
| Durik, M; Roks, AJ; Sevá Pessôa, B | 1 |
| Fletcher, JA; Matthew Morris, E; Rector, RS; Thyfault, JP | 1 |
| Kumar, U; McNeill, JH; Yuen, VG; Zhou, K | 1 |
| Müller-Fielitz, H; Raasch, W | 1 |
| Briet, M; Schiffrin, EL | 1 |
| Fukahori, M; Hidaka, S; Inoue, N; Kawahara, S; Maruyama, M; Miura, N; Muguruma, M; Ohta, K; Yamada, K | 1 |
| Abdulkareem, A; Al-Daghri, N; Alenad, AM; Alnaami, AM; Alokail, MS; Chrousos, GP; Draz, HM; Sabico, S; Yakout, SM | 1 |
| Ailhaud, G; Boschmann, M; Engeli, S; Gorzelniak, K; Janke, J; Massiéra, F; Schling, P; Sharma, AM; Teboul, M | 1 |
| Morishita, R | 1 |
| Araiza, A; Dincer, UD; Knudson, JD; Kuo, L; Setty, S; Tune, JD; Zhang, C | 1 |
| Leiter, LA; Lewanczuk, RZ | 1 |
| Inoguchi, T; Nawata, H | 1 |
| Packer, CS | 1 |
| Dell'Oro, R; Grassi, G; Mancia, G; Quarti-Trevano, F; Scopelliti, F | 1 |
| Fukuda, N | 1 |
| Fujita, K; Funahashi, T; Hibuse, T; Hiuge, A; Kihara, S; Kumada, M; Kurata, A; Kuriyama, H; Maeda, N; Nishizawa, H; Ohashi, K; Okada, T; Shimomura, I; Sonoda, M; Yasui, A | 1 |
| Henriksen, EJ; Sowers, JR; Stump, CS; Wei, Y | 1 |
| Horiuchi, M; Iwai, M; Mogi, M | 1 |
| Eguchi, S; Suzuki, H | 1 |
| Fujita, T | 1 |
| Vinson, GP | 1 |
| Ferder, L; Inserra, F; Martínez-Maldonado, M | 1 |
| Cao, TB; Li, ZB; Liu, DY; Ma, LQ; Wang, LJ; Zhang, LL; Zhang, YP; Zhu, ZM | 1 |
| Ageno, W; Dentali, F; Romualdi, E | 1 |
| Balogh, Z; Fóris, G; Fülöp, P; Kassai, A; Kosztáczky, B; Paragh, G; Seres, I; Varga, Z | 1 |
| Henriksen, EJ | 1 |
| Cooper, SA; Habibi, J; Lastra, G; Manrique, C; Sowers, JR; Stas, S; Wei, Y; Whaley-Connell, A | 1 |
| Diz, DI; Gilliam-Davis, S; Kasper, SO; Payne, VS; Robbins, ME; Tommasi, EN | 1 |
| Petkow-Dimitrow, P | 1 |
| Cao, G; Mastai, R; Mella, J; Muñoz, MC; Pereyra, L; Toblli, JE | 1 |
| Mitsuyama, K | 1 |
22 review(s) available for angiotensin ii and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Metabolic Syndrome and Cardiac Remodeling Due to Mitochondrial Oxidative Stress Involving Gliflozins and Sirtuins.
Topics: Angiotensin II; Cardiovascular Diseases; Diabetes Mellitus; Fibrosis; Humans; Hypertension; Metabolic Syndrome; Oxidative Stress; Sirtuins; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Remodeling | 2023 |
The (pro)renin receptor: an emerging player in hypertension and metabolic syndrome.
Topics: Angiotensin II; Animals; Autophagy; Blood Pressure; Disease Models, Animal; Glucose; Humans; Hypertension; Lipid Metabolism; Metabolic Syndrome; Proton-Translocating ATPases; Receptors, Cell Surface; Renin; Renin-Angiotensin System; Vacuolar Proton-Translocating ATPases; Wnt Signaling Pathway | 2019 |
Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II.
Topics: Albuminuria; Angiotensin II; Animals; Cardio-Renal Syndrome; Humans; Insulin Resistance; Kidney Glomerulus; Metabolic Syndrome; Signal Transduction | 2013 |
Roles of renal proximal tubule transport in acid/base balance and blood pressure regulation.
Topics: Acid-Base Equilibrium; Angiotensin II; Animals; Biological Transport; Blood Pressure; Humans; Kidney Tubules, Proximal; Metabolic Syndrome | 2014 |
Oxidized HDL is a potent inducer of adipogenesis and causes activation of the Ang-II and 20-HETE systems in human obese females.
Topics: Adipocytes; Adipogenesis; Adiponectin; Adult; Angiotensin II; Blood Pressure; Body Mass Index; Case-Control Studies; F2-Isoprostanes; Female; Gene Expression Regulation; Heme Oxygenase-1; Humans; Hydroxyeicosatetraenoic Acids; Lipoproteins, LDL; Metabolic Syndrome; Middle Aged; Obesity; Primary Cell Culture; Tumor Necrosis Factor-alpha | 2016 |
Chymase as an important target for preventing complications of metabolic syndrome.
Topics: Angiotensin II; Animals; Atherosclerosis; Chymases; Diabetes Complications; Diabetic Retinopathy; Fatty Liver; Humans; Hypertension; Matrix Metalloproteinase 9; Metabolic Syndrome; Mice; Transforming Growth Factor beta | 2010 |
Increased cord blood angiotensin II concentration is associated with decreased insulin sensitivity in the offspring of mothers with gestational diabetes mellitus.
Topics: Angiotensin II; Birth Weight; Blood Glucose; Diabetes, Gestational; Female; Fetal Blood; Glucose Tolerance Test; Homeostasis; Humans; Infant; Infant, Newborn; Insulin; Insulin Resistance; Male; Maternal-Fetal Exchange; Metabolic Syndrome; Pregnancy; Reference Values; Risk Factors | 2013 |
The renin-angiotensin system, bone marrow and progenitor cells.
Topics: Adipogenesis; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bone Marrow; Erythropoiesis; Hematopoiesis; Humans; Kidney; Mesenchymal Stem Cells; Metabolic Syndrome; Myocytes, Cardiac; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Stem Cells; Tetrazoles; Valine; Valsartan | 2012 |
The role of angiotensin II in nonalcoholic steatohepatitis.
Topics: Angiotensin II; Animals; Chronic Disease; Fatty Liver; Humans; Insulin Resistance; Liver Cirrhosis; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Renin-Angiotensin System; Signal Transduction | 2013 |
Vascular actions of aldosterone.
Topics: Adipocytes; Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Vessels; Cardiovascular Diseases; Endothelin A Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Fibrosis; Gene Expression Regulation; Humans; Hypertension; Hypertrophy; Metabolic Syndrome; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Muscle, Smooth, Vascular; Oxidative Stress; Receptor, Endothelin A; Receptors, Mineralocorticoid; Renin-Angiotensin System; Signal Transduction; Sodium; Vasculitis; Vasoconstriction | 2013 |
The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?
Topics: Adipocytes; Adipose Tissue, Brown; Angiotensin II; Angiotensinogen; Animals; Humans; Hypertension; Insulin Resistance; Metabolic Syndrome; Mice; Obesity; Peptidyl-Dipeptidase A; Rats; Renin; Renin-Angiotensin System; Thermogenesis | 2003 |
Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Humans; Inflammation; Insulin Resistance; Metabolic Syndrome; Obesity; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System | 2005 |
NAD(P)H oxidase activation: a potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndrome.
Topics: Adipocytes; Angiotensin II; Animals; Diabetic Angiopathies; Enzyme Activation; Enzyme Inhibitors; Humans; Islets of Langerhans; Metabolic Syndrome; NADPH Oxidases; Oxidative Stress; Protein Kinase C | 2005 |
Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Heart Failure; Humans; Hypertension; Insulin Resistance; Metabolic Syndrome; Renin-Angiotensin System; Sympathetic Nervous System | 2006 |
[Development of animal models for the metabolic syndrome with hypertension].
Topics: Angiotensin II; Animals; Disease Models, Animal; Hypertension; Insulin Resistance; Metabolic Syndrome; Mice; Mutation; Obesity; Rats; Rats, Inbred SHR; Receptors, Cell Surface; Receptors, Leptin; Tumor Necrosis Factor-alpha | 2006 |
The metabolic syndrome: role of skeletal muscle metabolism.
Topics: Angiotensin II; Cytokines; Energy Metabolism; Humans; Hypertension; Inflammation; Insulin; Metabolic Syndrome; Mitochondria; Muscle, Skeletal; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System | 2006 |
Spotlight on renin. The renin system, salt-sensitivity and metabolic syndrome.
Topics: Adrenomedullin; Angiotensin II; Cardiovascular Diseases; Humans; Hypertension; Insulin Resistance; Metabolic Syndrome; Renin-Angiotensin System; Sodium Chloride | 2006 |
Inflammation and the metabolic syndrome: role of angiotensin II and oxidative stress.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; C-Reactive Protein; Humans; Hypertension; Inflammation Mediators; Metabolic Syndrome; NADPH Oxidases; Oxidative Stress; Reactive Nitrogen Species; Reactive Oxygen Species | 2006 |
Improvement of insulin sensitivity by antagonism of the renin-angiotensin system.
Topics: Adipose Tissue; Angiotensin II; Child; Diabetes Mellitus, Type 2; Glucose; Humans; Insulin Resistance; Metabolic Syndrome; Muscle, Skeletal; Renin-Angiotensin System | 2007 |
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.
Topics: Angiotensin II; Animals; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus, Type 2; Endothelium, Vascular; Humans; Hypertension; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Kidney Diseases; Metabolic Syndrome; Mineralocorticoids; Muscle, Skeletal; Myocardium; Oxidative Stress; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Factors; Signal Transduction | 2007 |
[New therapeutic targets for ACE inhibitors and angiotensin receptor blockers].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Losartan; Metabolic Syndrome; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Risk Reduction Behavior; Telmisartan; Treatment Outcome | 2007 |
[Multiphasic action of AT1 receptor blockers and their therapeutic effects for cardiovascular diseases].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Endothelium, Vascular; Humans; Insulin Resistance; MAP Kinase Kinase Kinase 5; Metabolic Syndrome; Oxidative Stress | 2008 |
2 trial(s) available for angiotensin ii and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome.
Topics: Adult; Angiotensin II; Arteries; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular System; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Hemodynamics; Humans; Insulin Resistance; Male; Metabolic Syndrome; Nitric Oxide Synthase; omega-N-Methylarginine; Photoplethysmography; Receptor, Angiotensin, Type 1; Telmisartan; Vascular Resistance | 2009 |
Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome.
Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Cholesterol, HDL; Female; Humans; Hypertension; Imidazolidines; Insulin; Male; Metabolic Syndrome; Middle Aged; Plasminogen Activator Inhibitor 1; Tetrazoles; Triglycerides; Young Adult | 2011 |
42 other study(ies) available for angiotensin ii and Cardiometabolic Syndrome
| Article | Year |
|---|---|
AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Autoantibodies; Dopamine; Dopaminergic Neurons; Endothelial Cells; Humans; Inflammation; Metabolic Syndrome; Neuroinflammatory Diseases; Parkinson Disease; Rats; Receptor, Angiotensin, Type 1 | 2023 |
Renin inhibition improves metabolic syndrome, and reduces angiotensin II levels and oxidative stress in visceral fat tissues in fructose-fed rats.
Topics: Adipocytes; Adipokines; Amides; Angiotensin II; Animals; Blood Glucose; Blood Pressure; Cell Size; Cholesterol; Feeding Behavior; Fructose; Fumarates; Insulin; Intra-Abdominal Fat; Male; Metabolic Syndrome; Oxidative Stress; Rats, Inbred WKY; Renin; Superoxide Dismutase; Systole; Thiobarbituric Acid Reactive Substances; Triglycerides | 2017 |
Nox4 genetic inhibition in experimental hypertension and metabolic syndrome.
Topics: Angiotensin II; Animals; Biomarkers; Blood Glucose; Blood Pressure; Cardiomegaly; Diet, High-Fat; Disease Models, Animal; Female; Fibrosis; Genetic Predisposition to Disease; Heart Rate; Hypertension; Male; Metabolic Syndrome; Mice, Inbred C57BL; Mice, Knockout; Myocardium; NADPH Oxidase 4; Phenotype; Reactive Oxygen Species; Time Factors; Triglycerides; Ventricular Remodeling | 2018 |
Cellular mechanisms of metabolic syndrome-related atrial decompensation in a rat model of HFpEF.
Topics: Angiotensin II; Animals; Atrial Remodeling; Calcium; Calcium Signaling; Cell Nucleus; Cytosol; Disease Models, Animal; Excitation Contraction Coupling; Heart Atria; Heart Failure; Heart Ventricles; Hypertension; Metabolic Syndrome; Myocytes, Cardiac; Rats; Sarcoplasmic Reticulum; Stroke Volume | 2018 |
A novel hamster nonalcoholic steatohepatitis model induced by a high-fat and high-cholesterol diet.
Topics: Angiotensin II; Animals; Body Weight; Cholesterol, Dietary; Chymases; Cricetinae; Diet, High-Fat; Disease Models, Animal; Liver; Liver Cirrhosis; Male; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Organ Size; Transforming Growth Factor beta | 2018 |
Combined maternal and postnatal high-fat diet leads to metabolic syndrome and is effectively reversed by resveratrol: a multiple-organ study.
Topics: Adipose Tissue; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Body Weight; Diet, High-Fat; Female; Glucose Tolerance Test; Male; Maternal Nutritional Physiological Phenomena; Metabolic Syndrome; Obesity; Pregnancy; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Resveratrol; Sirtuin 1; Triglycerides | 2018 |
Functional role of endothelial CXCL16/CXCR6-platelet-leucocyte axis in angiotensin II-associated metabolic disorders.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Aneurysm; Blood Platelets; Case-Control Studies; Cell Adhesion; Cells, Cultured; Chemokine CXCL16; Coculture Techniques; Disease Models, Animal; Endothelial Cells; Female; Humans; Leukocytes; Male; Metabolic Syndrome; Mice, Inbred C57BL; Mice, Knockout, ApoE; Middle Aged; Platelet Activation; Receptors, CXCR6; Signal Transduction | 2018 |
Novel mechanism for disrupted circadian blood pressure rhythm in a rat model of metabolic syndrome--the critical role of angiotensin II.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Circadian Rhythm; Disease Models, Animal; Hypertension; Male; Metabolic Syndrome; Rats, Inbred SHR; Rats, Inbred WKY | 2013 |
Central insulin-angiotensin II interaction in blood pressure regulation in fructose overloaded rats.
Topics: Angiotensin II; Animals; Blood Pressure; Fructose; Hypothalamus; Injections, Intraventricular; Insulin; Insulin Resistance; Male; MAP Kinase Signaling System; Metabolic Syndrome; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasoconstrictor Agents; Vasomotor System | 2013 |
A mechanism underlying hypertensive occurrence in the metabolic syndrome: cooperative effect of oxidative stress and calcium accumulation in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta; Calcium; Cell Line; Diet, High-Fat; Hypertension; Male; Metabolic Syndrome; Mitochondria, Muscle; Muscle Contraction; Muscle, Smooth, Vascular; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase; Superoxides; Vasoconstriction | 2014 |
Association of angiotensin II type I and type II receptor genes polymorphisms with the presence of premature coronary disease and metabolic syndrome.
Topics: Adult; Alleles; Angiotensin II; Cholesterol; Coronary Disease; Genetic Predisposition to Disease; Humans; Lipids; Male; Metabolic Syndrome; Middle Aged; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Risk Factors | 2014 |
Angiotensin II and 1-7 during aging in Metabolic Syndrome rats. Expression of AT1, AT2 and Mas receptors in abdominal white adipose tissue.
Topics: Adipose Tissue, White; Aging; Angiotensin I; Angiotensin II; Animals; Gene Expression Regulation; Humans; Hypertension; Metabolic Syndrome; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2014 |
Glycyrrhizic acid can attenuate metabolic deviations caused by a high-sucrose diet without causing water retention in male Sprague-Dawley rats.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Administration, Oral; Angiotensin II; Animals; Dietary Sucrose; Edema; Glycyrrhizic Acid; Kidney; Leptin; Liver; Male; Metabolic Syndrome; Potassium; Rats; Rats, Sprague-Dawley; Sodium | 2014 |
Pentoxifylline alleviates hypertension in metabolic syndrome: effect on low-grade inflammation and angiotensin system.
Topics: Angiotensin II; Animals; Disease Models, Animal; Hypertension; Inflammation; Male; Metabolic Syndrome; Pentoxifylline; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Vasodilator Agents | 2015 |
Consumption of polyphenol-rich peach and plum juice prevents risk factors for obesity-related metabolic disorders and cardiovascular disease in Zucker rats.
Topics: Angiotensin II; Animals; Biomarkers; Cardiovascular Diseases; Chemokine CCL2; Fruit and Vegetable Juices; Insulin; Intercellular Adhesion Molecule-1; Leptin; Male; Metabolic Syndrome; NF-kappa B; Obesity; Polyphenols; PPAR gamma; Prunus domestica; Prunus persica; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Risk Factors; RNA, Messenger; Weight Gain | 2015 |
Angiotensin II Reduces Lipoprotein Lipase Expression in Visceral Adipose Tissue via Phospholipase C β4 Depending on Feeding but Increases Lipoprotein Lipase Expression in Subcutaneous Adipose Tissue via c-Src.
Topics: Angiotensin II; Animals; Ataxia Telangiectasia Mutated Proteins; Cells, Cultured; CSK Tyrosine-Protein Kinase; GTP-Binding Protein alpha Subunits, Gq-G11; Intra-Abdominal Fat; Lipoprotein Lipase; Male; Metabolic Syndrome; p38 Mitogen-Activated Protein Kinases; Phospholipase C beta; Rats; Rats, Wistar; RNA Interference; RNA, Messenger; RNA, Small Interfering; Signal Transduction; src-Family Kinases; Subcutaneous Fat; Triglycerides | 2015 |
Adipocyte-Specific Mineralocorticoid Receptor Overexpression in Mice Is Associated With Metabolic Syndrome and Vascular Dysfunction: Role of Redox-Sensitive PKG-1 and Rho Kinase.
Topics: Adipocytes; Aldosterone; Angiotensin II; Animals; Cells, Cultured; Corticosterone; Culture Media, Conditioned; Elastin; Humans; Intra-Abdominal Fat; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Oxidation-Reduction; Phosphorylation; Receptors, Mineralocorticoid; rho-Associated Kinases | 2016 |
Fenofibrate Therapy Restores Antioxidant Protection and Improves Myocardial Insulin Resistance in a Rat Model of Metabolic Syndrome and Myocardial Ischemia: The Role of Angiotensin II.
Topics: Angiotensin II; Animals; Antioxidants; Catalase; Disease Models, Animal; Fenofibrate; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Myocardial Infarction; NADPH Oxidase 4; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphoinositide-3 Kinase Inhibitors; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Superoxide Dismutase; Superoxide Dismutase-1; Triglycerides | 2016 |
Chronic production of peroxynitrite in the vascular wall impairs vasorelaxation function in SHR/NDmcr-cp rats, an animal model of metabolic syndrome.
Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Vessels; Blotting, Western; Enzyme Activation; Immunoenzyme Techniques; Luminescence; Male; Metabolic Syndrome; NADPH Oxidases; Nitric Oxide Synthase Type III; Nitroprusside; Peroxynitrous Acid; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Telmisartan; Tyrosine; Vasoconstrictor Agents; Vasodilation | 2009 |
Hyperuricemia, cardiovascular disease, and the metabolic syndrome.
Topics: Angiotensin II; Cardiovascular Diseases; Humans; Hypertension; Hyperuricemia; Metabolic Syndrome; Obesity; Renin-Angiotensin System; Risk Factors; Uric Acid | 2009 |
Design, synthesis, and docking studies of novel benzimidazoles for the treatment of metabolic syndrome.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Cell Membrane; Cells, Cultured; Drug Design; Liver; Metabolic Syndrome; Models, Chemical; PPAR gamma; Radioligand Assay; Rats; Receptor, Angiotensin, Type 1; Transcriptional Activation | 2010 |
Hypertension, obesity, and inflammation: the complex designs of a deadly trio.
Topics: Adaptive Immunity; Angiotensin II; Atherosclerosis; Genes, ras; Humans; Hypertension; Inflammation; Insulin Resistance; Metabolic Syndrome; Obesity; Oxidative Stress | 2010 |
Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome.
Topics: Angiotensin II; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Glycated Hemoglobin; Hypertension; Kidney; Male; Metabolic Syndrome; Proteinuria; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Sitagliptin Phosphate; Triazoles; Vasoconstriction; Vasoconstrictor Agents | 2010 |
Coronary vascular dysfunction promoted by oxidative-nitrative stress in SHRSP.Z-Lepr(fa) /IzmDmcr rats with metabolic syndrome.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Coronary Vessels; Cyclic GMP; Disease Models, Animal; Endothelium, Vascular; Insulin; Lipids; Metabolic Syndrome; Nitric Oxide; Nitroprusside; Oxidative Stress; Rats; Rats, Inbred Strains; Vasodilation | 2010 |
[Effect of irbesartan of the function of hemocoagulative component of hemostasis in patients with arterial hypertension during metabolic syndrome].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Blood Pressure; Female; Follow-Up Studies; Hemostasis; Humans; Hypertension; Irbesartan; Male; Metabolic Syndrome; Middle Aged; Tetrazoles; Treatment Outcome | 2010 |
Role of angiotensin II-mediated AMPK inactivation on obesity-related salt-sensitive hypertension.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Diet, High-Fat; Disease Models, Animal; Hypertension; Kidney; Losartan; Metabolic Syndrome; Metformin; Mice; Mice, Inbred C57BL; Obesity; Phosphorylation; Sodium; Sodium, Dietary | 2012 |
The effects of phentolamine on fructose-fed rats.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Blood Glucose; Blood Pressure; Disease Models, Animal; Fructose; Hypertension; Insulin; Male; Metabolic Syndrome; Norepinephrine; Phentolamine; Rats; Rats, Wistar; Reactive Nitrogen Species; Uric Acid | 2012 |
Angiotensin II impairs glucose utilization in obese Zucker rats by increasing HPA activity via an adrenal-dependent mechanism.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Angiotensin II; Animals; Blood Glucose; Corticosterone; Disease Models, Animal; Glucose Intolerance; Glucose Tolerance Test; Hyperglycemia; Hypothalamo-Hypophyseal System; Insulin; Insulin Secretion; Male; Metabolic Syndrome; Obesity; Pituitary-Adrenal System; Random Allocation; Rats; Rats, Zucker; Up-Regulation | 2013 |
[Effects of liver hydrolysate on the blood glucose in metabolic syndrome model rats (SHR/NDmcr-cp)].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Blood Glucose; Depression, Chemical; Disease Models, Animal; Glucose Tolerance Test; Glycated Hemoglobin; Insulin Resistance; Liver; Male; Metabolic Syndrome; Oxidative Stress; Protein Hydrolysates; Rats; Rats, Inbred SHR | 2013 |
Metabolic syndrome biomarkers and early breast cancer in Saudi women: evidence for the presence of a systemic stress response and/or a pre-existing metabolic syndrome-related neoplasia risk?
Topics: Adipokines; Adult; Angiotensin II; Arabs; Biomarkers, Tumor; Blood Pressure; Breast Neoplasms; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cross-Sectional Studies; Early Detection of Cancer; Enzyme-Linked Immunosorbent Assay; Female; Humans; Insulin; Logistic Models; Metabolic Syndrome; Middle Aged; Multivariate Analysis; Obesity; Odds Ratio; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Risk Assessment; Risk Factors; Saudi Arabia; Stress, Physiological; Triglycerides; Tumor Necrosis Factor-alpha | 2013 |
Is vascular endothelial growth factor a missing link between hypertension and inflammation?
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Extracellular Matrix Proteins; Genes, Lethal; Humans; Hypertension; Inflammation; Metabolic Syndrome; Mice; Mice, Knockout; Mice, Transgenic; Muscle, Skeletal; Myosin Heavy Chains; Nonmuscle Myosin Type IIB; Rats; Transfection; Transgenes; Vascular Endothelial Growth Factor A | 2004 |
Coronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptors.
Topics: Angiotensin II; Animals; Blood Pressure; Coronary Circulation; Dietary Fats; Dogs; Female; Gene Expression; In Vitro Techniques; Male; Metabolic Syndrome; Obesity; Oxygen Consumption; Physical Exertion; Prediabetic State; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasoconstriction; Vasoconstrictor Agents | 2005 |
Angiotensin II as a multifunctional hormone: a regulator of haemodynamics and metabolism with potential roles in the etiologies of hypertension and the metabolic syndrome.
Topics: Angiotensin II; Animals; Atherosclerosis; Blood Glucose; Cholesterol; Hemodynamics; Hypertension; Metabolic Syndrome; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2006 |
Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation.
Topics: Adiponectin; Adipose Tissue; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Cells, Cultured; Female; Gene Expression Regulation; Imidazoles; Kidney Diseases; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Oxidative Stress; Plasminogen Activator Inhibitor 1; Reactive Oxygen Species; RNA, Messenger; Serum Amyloid A Protein; Signal Transduction; Tetrazoles; Tumor Necrosis Factor-alpha | 2006 |
Emerging concept of adipogenesis regulation by the renin-angiotensin system.
Topics: Adipogenesis; Adipose Tissue; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cell Differentiation; Cells, Cultured; Humans; Metabolic Syndrome; Renin-Angiotensin System; Stem Cells | 2006 |
Adiponectin versus angiotensin II: Key pathological role of their misbalance.
Topics: Adiponectin; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Diabetes Mellitus, Type 2; Humans; Metabolic Syndrome; Obesity; Reactive Oxygen Species; Signal Transduction | 2006 |
Angiotensin II, corticosteroids, type II diabetes and the metabolic syndrome.
Topics: Adipocytes; Adrenal Cortex Hormones; Angiotensin II; Animals; Diabetes Mellitus, Type 2; Feedback, Physiological; Humans; Insulin Resistance; Metabolic Syndrome; Models, Biological; Renin-Angiotensin System | 2007 |
[Renin-angiotensin system in mesenteric adipose tissues in rats with metabolic syndrome].
Topics: Adipocytes; Adipose Tissue; Angiotensin II; Angiotensinogen; Animals; Benzimidazoles; Biphenyl Compounds; Calcium; Captopril; Cells, Cultured; Male; Metabolic Syndrome; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles | 2006 |
The metabolic syndrome and the risk of thrombosis.
Topics: Adiponectin; Adipose Tissue; Angiotensin II; Anthropometry; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Cytokines; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Male; Metabolic Syndrome; Obesity; Plasminogen; Prevalence; Prospective Studies; Risk Factors; Stroke; Thrombophilia; Thrombosis; Tissue Plasminogen Activator | 2007 |
The association between angiotensin II-induced free radical generation and membrane fluidity in neutrophils of patients with metabolic syndrome.
Topics: Adult; Angiotensin I; Angiotensin II; Anticholesteremic Agents; Cholesterol; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Female; Fluvastatin; Homeostasis; Humans; Hypercholesterolemia; Indoles; Leukotriene C4; Male; Membrane Fluidity; Metabolic Syndrome; Middle Aged; Neutrophils; Pertussis Toxin; Protein Prenylation; Quinacrine; Signal Transduction; Superoxides; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 2006 |
Long-term AT1 receptor blockade improves metabolic function and provides renoprotection in Fischer-344 rats.
Topics: Aging; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Imidazoles; Insulin; Kidney; Leptin; Male; Metabolic Syndrome; Metabolism; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles | 2007 |
ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats.
Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Disease Models, Animal; Fatty Liver; Interleukin-6; Irbesartan; Liver; Liver Cirrhosis; Male; Metabolic Syndrome; Obesity; Perindopril; Rats; Rats, Zucker; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2008 |